Medivation, Inc. Community Page | What other sites are saying about Medivation, Inc.

Medivation, Inc.

(NQ: MDVN)

48.86 USD -0.95 (-1.91%)

Official Closing Price / Updated: 8:10 PM EDT, May 24, 2013 / Add to My Watchlist

(MDVN) Community Analysis from

READ MORE (MDVN)

Bulls REASONS TO BUY

agree

0 votes

Prostate Cancer treatment

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 25, 2013

(MDVN) Medivation Analyst Neutral on Shares

(Stock Blog Hub, 1/2/13)

We recently reiterated a Neutral recommendation on Medivation, Inc. (MDVN). Medivation received a major boost in late August when the FDA approved its prostate cancer treatment,...(read more)

(MDVN) Ignore the Smartest Guys in the Room – All 8,600 of Them

(Stock Blog Hub, 1/15/13)

Everyone loves the long ball. Home runs are exciting. Sammy Sosa and Mark McGwire’s steroid-fueled race in 1998 brought baseball back from the damage caused by...(read more)

Viking Global Starts Medivation Stake (MDVN)

(market folly, 8/28/12)

Andreas Halvorsen's hedge fund firm Viking Global recently filed a 13G with the SEC on shares of Medivation (MDVN). Per the filing, Viking has revealed a 5.3% ownership stake in MDVN with just...(read more)

View all posts about Medivation (MDVN)

Medivation (MDVN) Company Overview

There is no analysis for MDVN yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates